Johnson & Johnson refreshed its financial guidance following its split from Kenvue. The healthcare behemoth offset most of the financial impact of the split because the exchange offer lowered its shar
Johnson & Johnson (JNJ) on Wednesday released its first earnings forecast as a standalone pharmaceutical and medical devices company, estimating double-digit growth in earnings this year.
Johnson & Johnson (NYSE:JNJ) has released new financial results for previous quarters that strip out the consumer-health unit that was recently hived off into a new company called Kenvue. J&J, which i
Johnson & Johnson maintains its quarterly dividend of $1.19 a share after spinning out consumer-health company Kenvue, although it lowers its earnings and sales projections.
Johnson & Johnson JNJ, +0.01% updated on Wednesday its 2023 financial guidance in the wake of the Kenvue Inc. KVUE, -0.48% separation that was completed last week. The drug maker now expects full-year

Options Bulls Pick Up on Blue-Chip's Split-Off

02:44pm, Monday, 28'th Aug 2023
Dow member Johnson & Johnson (JNJ) last week completed a split-off exchange offer of 1.53 billion shares of Kenvue Inc (NYSE:KVUE) worth roughly $40 billion.
Small investors earned a nice payday of more than $1,000 if they tendered 99 shares of stock in the swap, which expired last week.
Johnson & Johnson recently completed the Kenvue spinoff. We outline the impacts on its dividend payouts from this spinoff. I analyzed its dividend payout both using simple payout ratios and also using
Here are some of the tickers on my radar for Thursday, Aug. 24, taken directly from my reporter's notebook.
Kenvue announced that Wednesday, August 23, marked its first day as a fully independent company after it completed its separation from Johnson & Johnson (NYSE:JNJ). The consumer health company, whose
Johnson & Johnson investors were able to exchange less than a quarter of their shares for the consumer split off. The company will update financial guidance next week
Kenvue Inc. KVUE, +3.67% kicks off life as a fully independent public company Wednesday after completing its separation from Johnson & Johnson JNJ, -0.79%, the company said in a release. J&J accepted
Kenvue (NYSE: KVUE) stock price jumped by more than 3% on Tuesday as investors reacted to the oversubscription of an exchange offer for Johnson & Johnson (NYSE: JNJ). The stock jumped to a high of $23
J&J holders who participated in the exchange offer can choose which J&J shares they want to use for their cost basis in Kenvue.

J&J spinoff Kenvue to join S&P 500 on Friday

11:40am, Tuesday, 22'nd Aug 2023
Johnson & Johnson (NYSE:JNJ)'s consumer health spinoff Kenvue will replace Advance Auto Parts in the S&P 500 index effective Friday, August 25, the index announced.  This comes after J&J offered to
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE